跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臺北醫學大學
電話
+886-2-27361661
網站
http://www.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(1451)
專案
(9784)
研究成果
(32547)
資料集
(1018)
活動
(9)
指紋
查看啟用 臺北醫學大學 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mouse
68%
Neoplasm
61%
Disease
59%
Cohort Study
49%
Inflammation
38%
Reactive Oxygen Metabolite
30%
Liver Cell Carcinoma
29%
Antioxidant
28%
Lung Cancer
27%
Breast Cancer
27%
Colorectal Cancer
25%
Diabetes Mellitus
24%
Lipopolysaccharide
24%
Randomized Controlled Trial
24%
Cytotoxicity
23%
Epidermal Growth Factor Receptor
22%
Prevalence
22%
Infection
22%
Cytokine
21%
Injury
20%
Chronic Kidney Failure
20%
Nitric Oxide
20%
Chemotherapy
20%
Tumor Necrosis Factor
19%
Nanoparticle
19%
Prostate Cancer
19%
Biological Marker
19%
Non Small Cell Lung Cancer
18%
Western Blot
18%
IC50
18%
Anti-Inflammatory Drug
17%
Cardiovascular Disease
16%
Adverse Event
16%
Mitogen Activated Protein Kinase
16%
Symptom
15%
Phosphotransferase
15%
Glioblastoma
14%
Tumor Growth
14%
Hemodialysis
14%
Combination Therapy
14%
Protein P53
14%
Non Insulin Dependent Diabetes Mellitus
14%
Receptor
14%
Nuclear Factor
13%
Calcium Ion
13%
Cancer Growth
13%
Brain Ischemia
13%
Antiinfective Agent
13%
Caspase 3
13%
Cyclooxygenase 2
13%
Atrial Fibrillation
12%
Carcinogenesis
12%
Comorbidity
12%
Metastasis
12%
Mouth Cancer
12%
microRNA
12%
Pharmacokinetics
12%
Mouse Model
12%
Cell Viability
12%
Lung Adenocarcinoma
11%
Inducible Nitric Oxide Synthase
11%
Anticarcinogen
11%
Recurrent Disease
11%
Alternative Complement Pathway C3 C5 Convertase
10%
Overall Survival
10%
Case-Control Study
10%
Cisplatin
10%
Asthma
10%
Drug Resistance
10%
Sepsis
10%
Colon Cancer
10%
Placebo
9%
Chronic Obstructive Lung Disease
9%
Clinical Trial
9%
Chitosan
9%
Parkinson's Disease
9%
Resveratrol
9%
Rat Model
9%
Survival Rate
9%
Small Interfering RNA
9%
Heme Oxygenase 1
9%
Interleukin 6
9%
Doxorubicin
8%
Mouth Squamous Cell Carcinoma
8%
Therapeutic Effect
8%
Heart Failure
8%
Alzheimer's Disease
8%
Mortality Rate
8%
Hypoxia
8%
Gelatinase B
8%
Vaccination Policy
8%
Protein Kinase C
8%
Integrin
8%
Mitogen Activated Protein Kinase 3
8%
Histone Deacetylase Inhibitor
8%
Vasculotropin
8%
Stomach Cancer
8%
Adenosine Triphosphate
7%
Antioxidant Capacity
7%
Medicine and Dentistry
Neoplasm
54%
Meta-Analysis
53%
Malignant Neoplasm
50%
Disease
47%
Cohort Analysis
43%
Systematic Review
40%
In Vitro
33%
Randomized Controlled Trial
32%
Breast Cancer
31%
Cancer Cell
30%
Apoplexy
29%
Odds Ratio
28%
Metastatic Carcinoma
26%
Symptom
25%
Programmed Cell Death
24%
Hazard Ratio
24%
Prevalence
22%
Infection
21%
Injury
21%
Diabetes Mellitus
20%
Chronic Kidney Disease
19%
Diabetes
19%
Lung Cancer
19%
Hepatocellular Carcinoma
19%
Biological Marker
18%
Colorectal Cancer
16%
COVID-19
16%
Magnetic Resonance Imaging
16%
Signal Transduction
15%
Radiation Therapy
15%
Surgery
15%
Prostate Cancer
15%
Maturity Onset Diabetes of the Young
15%
Atrial Fibrillation
14%
Logistic Regression Analysis
14%
Quality of Life
14%
Recurrent Disease
14%
Computer Assisted Tomography
14%
Drug Therapy
14%
Body Mass Index
13%
Overall Survival
13%
Medicine
13%
Diagnosis
12%
Cancer
12%
Cardiovascular Disease
12%
Health Care Cost
12%
Gene Expression
12%
Oral Cancer
12%
Epidermal Growth Factor Receptor
11%
Proportional Hazards Model
11%
Oxidative Stress
11%
Brain Ischemia
11%
Supplementation
11%
Retrospective Cohort Study
11%
Cross Sectional Study
11%
Platelet
11%
Survival Rate
10%
Reactive Oxygen Species
10%
Case-Control Study
10%
Adverse Event
10%
Non Small Cell Lung Cancer
10%
Cell Proliferation
10%
Isotopes of Calcium
10%
Fibroblast
10%
Mesenchymal Stem Cell
9%
Carcinogenesis
9%
Retrospective Study
9%
Antioxidant
9%
Upregulation
9%
Endothelial Cell
9%
Sepsis
9%
Cancer Growth
9%
Pediatrics
9%
Hemodialysis
9%
Tumor Necrosis Factor
9%
Mouth Squamous Cell Carcinoma
8%
Combination Therapy
8%
Autophagy
8%
Bleeding
8%
Mortality Rate
8%
Rehabilitation Engineering
8%
Protein Expression
8%
Outpatient
8%
Tumor Progression
8%
Cardiovascular System
8%
Implant
8%
Health Care
8%
Surgeon
8%
Cytokine
8%
Cytotoxicity
7%
Intensive Care Unit
7%
Osteoarthritis
7%
Observational Study
7%
microRNA
7%
Stem Cell
7%
Ovarian Cancer
7%
Glioblastoma
7%
Macrophage
7%
Clinician
7%
Mitogen-Activated Protein Kinase
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
58%
Mouse
33%
Gene Expression
26%
Cohort Study
22%
Signal Transduction
21%
Messenger RNA
19%
Stem Cell
19%
Promoter Region
17%
MicroRNA
16%
Carcinogenesis
16%
Cell Proliferation
16%
Autophagy
16%
Eicosanoid Receptor
14%
Epidermal Growth Factor Receptor
14%
Oxidative Stress
14%
Prevalence
13%
Upregulation
13%
Kinase
12%
Phosphotransferase
12%
Cardiac Muscle Cell
12%
Fibroblast
12%
down Regulation
12%
Protein Expression
12%
Cell Migration
11%
Genotyping
11%
Atrial Fibrillation
11%
Tumor Progression
10%
Anticancer
10%
P53
10%
Methylation
10%
Overall Survival
10%
Drug Resistance
10%
Western Blot
10%
Macrophage
9%
Mesenchymal-Epithelial Transition
9%
Catenin
9%
Genetics
9%
Cell Death
9%
Single-Nucleotide Polymorphism
9%
Enzyme
9%
Angiogenesis
9%
Platelet
9%
Cancer Stem Cell
9%
Colon
9%
Hemodialysis
8%
Body Mass
8%
Mitogen-Activated Protein Kinase
8%
Integrin
8%
Synapsin I
8%
Cytotoxicity
8%
Survival Rate
8%
Case-Control Study
7%
Transcription
7%
Glucose Blood Level
7%
Surface Property
7%
Lipopolysaccharide
7%
Mitochondrion
7%
Cell Growth
7%
Tumor Necrosis Factor
7%
Cytokine
7%
Blood Pressure
7%
Insulin Resistance
7%
Allele
7%
DNA Methylation
6%
Cyclooxygenase
6%
RNA
6%
Epigenetics
6%
Genetic Divergence
6%
Transcription Factors
6%
Blood Level
6%
Wild Type
6%
Nitric Oxide Synthase
6%
Cell Invasion
6%
Cell Cycle
6%
Gene Polymorphism
6%
STAT3
5%
Small Interfering RNA
5%
Metabolic Pathway
5%
Homeostasis
5%
Proteomics
5%
Cell Viability
5%
Histone Deacetylase
5%
Triglyceride
5%
Lipid
5%
T Cell
5%
Superoxide Dismutase
5%
Nitric Oxide
5%
Secretion (Process)
5%
Microarrays
5%
Mouse Model
5%
Comorbidity
5%
Endoplasmic Reticulum Stress
5%
Randomized Controlled Trial
5%
Antineoplastic Activity
5%
Hyperglycemia
5%
Osteoblast
5%
Vascular Endothelial Growth Factor
5%
N-Terminus
5%
Body Weight
5%
Thyroid Hormone
5%